Last Price$3.4(0.9%)
Market Cap$1,625.6M
(6.0%)
Peers median - 9.3%
2.4%
Peers median - 1.9%
0.0%
Peers median - 72.3%
(313.9%)
Peers median - 7.5%
Competing with CLOV
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$1,625.6M | 4.9 | $1.8 46.9% overvalued | 326.1% | $1,371.1M | $33.3M | (6.0%) | 2.4% | 26.6% | (313.9%) | 0.0% | |
$447.6B | 6.0 | $647.0 33.1% undervalued | 0.5% | $396.6B | $20.7B | 7.9% | 5.2% | 21.6% | 17.9% | 75.0% | |
$95.9B | 6.3 | $326.7 22.6% overvalued | (15.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 46.8% | 18.1% | 75.4% | |
$90.5B | 5.8 | $365.7 15.1% undervalued | (5.5%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $192.0 195.4% undervalued | (10.5%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$30.6B | 5.4 | $155.2 164.9% undervalued | (24.9%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 10.2% | 73.3% | |
$30.4B | 6.0 | $807.5 222.7% undervalued | (27.1%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 100.0% | 35.9% | 71.3% | |
$18.8B | 5.9 | $456.4 40.5% undervalued | (19.3%) | $40.6B | $544.0M | 19.2% | 1.3% | 11.6% | 30.6% | 69.4% | |
$3,551.3M | 6.1 | $24.7 68.4% undervalued | 0.3% | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (4.9%) | 29.5% | |
$2,959.1M | 5.3 | $8.8 43.2% overvalued | 190.9% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 11.0% | (398.3%) | 15.5% | |
$65.5M | 5.0 | $46.2 463.2% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
Compare CLOV Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Clover Health Investments, Corp.CLOV
1.0x
8.8%
(82.2%)
(3.1%)
Median Peer Set
0.4x
9.8%
(7.6%)
1.1%
Alignment Healthcare, Inc.ALHC
0.9x
48.3%
(15.2%)
(4.7%)
Bright Health Group, Inc.BHG
N/A
(51.9%)
86.2%
(103.4%)
Cigna CorporationCI
0.5x
26.6%
(93.1%)
0.1%
Centene CorporationCNC
0.2x
5.9%
27.4%
2.0%
CVS Health CorporationCVS
0.4x
4.2%
(43.6%)
1.2%
Elevance Health Inc.ELV
0.5x
3.2%
0.5%
3.4%
Humana Inc.HUM
0.2x
10.7%
(50.2%)
1.0%
Molina Healthcare, Inc.MOH
0.3x
19.3%
9.2%
2.9%
Oscar Health, Inc.OSCR
0.2x
56.5%
N/A
0.3%
UnitedHealth Group IncorporatedUNH
1.2x
8.9%
(35.7%)
3.6%
Compare CLOV Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Clover Health Investments, Corp. (CLOV) revenue growth compare to peers and the industry?
Clover Health Investments, Corp. (CLOV) revenue growth is (6.0%), compared to the peers' median of 9.3%.
2. How does Clover Health Investments, Corp. (CLOV) Free Cash Flow (FCF) margin compare to peers and the industry?
Clover Health Investments, Corp. (CLOV) FCF margin is 2.4%, compared to the peers' median of 1.9%.
3. How does Clover Health Investments, Corp. (CLOV) Total Debt to Equity ratio compare to peers and the industry?
Clover Health Investments, Corp. (CLOV) Total Debt to Equity ratio is 0.0%, compared to the peers' median of 72.3%.
4. How does Clover Health Investments, Corp. (CLOV) ROIC (Return on Invested Capital) compare to peers and the industry?
Clover Health Investments, Corp. (CLOV) ROIC is (313.9%), compared to the peers' median of 7.5%.